173 related articles for article (PubMed ID: 31857774)
1. Aberrant methylation of secreted protein acidic and rich in cysteine gene and its significance in gastric cancer.
Shao S; Zhou NM; Dai DQ
World J Gastroenterol; 2019 Dec; 25(46):6713-6727. PubMed ID: 31857774
[TBL] [Abstract][Full Text] [Related]
2. Aberrant promoter methylation of SPARC in ovarian cancer.
Socha MJ; Said N; Dai Y; Kwong J; Ramalingam P; Trieu V; Desai N; Mok SC; Motamed K
Neoplasia; 2009 Feb; 11(2):126-35. PubMed ID: 19177197
[TBL] [Abstract][Full Text] [Related]
3. Identification of hypermethylation in hepatocyte cell adhesion molecule gene promoter region in bladder carcinoma.
Tao J; Liu Q; Wu X; Xu X; Zhang Y; Wang Q; Luo C
Int J Med Sci; 2013; 10(13):1860-7. PubMed ID: 24324362
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of SPARC in human hepatocellular carcinoma and its clinical implication.
Zhang Y; Yang B; Du Z; Bai T; Gao YT; Wang YJ; Lou C; Wang FM; Bai Y
World J Gastroenterol; 2012 May; 18(17):2043-52. PubMed ID: 22563191
[TBL] [Abstract][Full Text] [Related]
5. Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer.
Chen ZY; Zhang JL; Yao HX; Wang PY; Zhu J; Wang W; Wang X; Wan YL; Chen SW; Chen GW; Liu YC
Sci Rep; 2014 Dec; 4():7035. PubMed ID: 25516351
[TBL] [Abstract][Full Text] [Related]
6. SPARC is down-regulated by DNA methylation and functions as a tumor suppressor in T-cell lymphoma.
Yan J; Zhang J; Zhang X; Li X; Li L; Li Z; Chen R; Zhang L; Wu J; Wang X; Sun Z; Fu X; Chang Y; Nan F; Yu H; Wu X; Feng X; Li W; Zhang M
Exp Cell Res; 2018 Mar; 364(2):125-132. PubMed ID: 29277504
[TBL] [Abstract][Full Text] [Related]
7. [Methylation and demethylation of SOX2 gene promoter in BGC-823 gastric cancer cells].
Wei B; Liu G; Cai HL; Li GP; Huang HQ; Luo Q; Huang ZJ
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(32):2548-53. PubMed ID: 27596549
[TBL] [Abstract][Full Text] [Related]
8. Methylation-mediated expression of SPARC is correlated with tumor progression and poor prognosis of breast cancer.
Li XL; Li JL; Qiu DJ; Ma L
Neoplasma; 2022 Jul; 69(4):794-806. PubMed ID: 35400166
[TBL] [Abstract][Full Text] [Related]
9. Potential Prognostic Role of
Fabrizio FP; Sparaneo A; Fontana A; Mazza T; Graziano P; Pantalone A; Parente P; Centra F; Orlando N; Trombetta D; Torre A; Ferretti GM; Taurchini M; Micco CMD; Maiello E; Fazio VM; Rossi A; Muscarella LA
Cells; 2020 Jun; 9(6):. PubMed ID: 32580473
[TBL] [Abstract][Full Text] [Related]
10. Aberrant methylation of secreted protein, acidic and rich in cysteine in human laryngeal and hypopharyngeal carcinoma.
He Q; Wei J; Zhang J; Jiang H; Wang S; Zhou X; Zhang Z; Huang G; Watanabe H; Su J
Oncol Lett; 2011 Jul; 2(4):725-729. PubMed ID: 22848256
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients.
Singh N; Rashid S; Rashid S; Dash NR; Gupta S; Saraya A
J Cancer Res Clin Oncol; 2020 Apr; 146(4):897-907. PubMed ID: 32146565
[TBL] [Abstract][Full Text] [Related]
12. MiR-1275 Targeting SPARC Promotes Gambogic Acid-Induced Inhibition of Gastric Cancer.
Cai A; Xia P; Zhou X; He Y; Lv J
Biochem Genet; 2023 Dec; 61(6):2481-2495. PubMed ID: 37118619
[TBL] [Abstract][Full Text] [Related]
13. Secreted protein acidic and rich in cysteine (SPARC) suppresses angiogenesis by down-regulating the expression of VEGF and MMP-7 in gastric cancer.
Zhang JL; Chen GW; Liu YC; Wang PY; Wang X; Wan YL; Zhu J; Gao HQ; Yin J; Wang W; Tian ML
PLoS One; 2012; 7(9):e44618. PubMed ID: 22957090
[TBL] [Abstract][Full Text] [Related]
14. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
15. Hypermethylation of the SPARC promoter and its prognostic value for prostate cancer.
Liu T; Qiu X; Zhao X; Yang R; Lian H; Qu F; Li X; Guo H
Oncol Rep; 2018 Feb; 39(2):659-666. PubMed ID: 29207175
[TBL] [Abstract][Full Text] [Related]
16. Hypermethylation and clinicopathological significance of RASAL1 gene in gastric cancer.
Chen H; Pan Y; Cheng ZY; Wang Z; Liu Y; Zhao ZJ; Fan H
Asian Pac J Cancer Prev; 2013; 14(11):6261-5. PubMed ID: 24377515
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of SPARC expression decreases gastric cancer cellular invasion and survival.
Yin J; Chen G; Liu Y; Liu S; Wang P; Wan Y; Wang X; Zhu J; Gao H
J Exp Clin Cancer Res; 2010 Jun; 29(1):59. PubMed ID: 20525171
[TBL] [Abstract][Full Text] [Related]
18. Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation.
Cao YM; Gu J; Zhang YS; Wei WJ; Qu N; Wen D; Liao T; Shi RL; Zhang L; Ji QH; Wang Y; Sun GH; Zhao YX; Wang YJ; Yu J; Zhu YX
Oncol Rep; 2018 Jan; 39(1):338-348. PubMed ID: 29115628
[TBL] [Abstract][Full Text] [Related]
19. SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response.
Cheetham S; Tang MJ; Mesak F; Kennecke H; Owen D; Tai IT
Br J Cancer; 2008 Jun; 98(11):1810-9. PubMed ID: 18458674
[TBL] [Abstract][Full Text] [Related]
20. Methylation of the SPARC gene promoter and its clinical implication in pancreatic cancer.
Gao J; Song J; Huang H; Li Z; Du Y; Cao J; Li M; Lv S; Lin H; Gong Y
J Exp Clin Cancer Res; 2010 Mar; 29(1):28. PubMed ID: 20338068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
